2026-04-02 Proof of concept for aqueous two-phase system-based extraction of cell-free DNA from plasma for liquid biopsy applications
2026-03-23 Cascading inertial microfluidics for high-throughput, multi-scale enrichment of tumor cells and intact clusters towards enhanced malignancy diagnosis
2026-03-23 Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence
2026-03-17 Peripheral blood mononuclear cell gene expression signatures predict long-term survivorship in canine DLBCL
2026-03-16 Spectroscopic fingerprinting of extracellular vesicles from diverse cellular origins by ATR-FTIR for vibrational biomarkers of vector–host interactions
2026-03-13 Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer
2026-03-06 Fragmentomic liquid biopsy enables early breast cancer detection, molecular subtyping and lymph node assessment
2026-03-02 Multimodal plasma and urinary cell-free DNA profiling improves risk stratification in newly diagnosed prostate cancer
2026-02-27 Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer
2026-02-27 Clinical impact of the methylation status of SMAD4 and AKR1B1 genes in a liquid biopsy sample as a prognostic marker for breast cancer
2026-02-26 Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma
2026-02-26 Small-nucleolar RNA host gene3 (SNHG3) and leukemia-associated non-coding IGF1R activator RNA 1 (LUNAR1) correlated with CRC patients’ clinical features: a step-toward ncRNA-precision
2026-02-20 Oncofetal chondroitin sulfate positive circulating tumor cells as prognostic biomarkers in early-stage melanoma
2026-02-20 Implementation of a 1021-gene liquid biopsy assay for real-world tumor genomic profiling in oncology practice
2026-02-14 Clinically interpretable extracellular vesicle gene model for Non-Invasive liver cancer diagnosis
2026-02-14 Ultrafast and specific miRNA quantification via single-molecule fluorescence quenching kinetics
2026-02-13 Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab
2026-02-11 A lncRNA and radiomics-based model for predicting the response of non-small cell lung cancer to chemo- and radio-therapy
2026-02-11 5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma
2026-02-03 Liquid biopsy of plasma and urinary CfDNA differentiates glioma recurrence from radiation brain necrosis in preclinical models
2026-02-03 Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients
2026-01-31 Early detection of aberrant cell fate and repair using circulating progenitor cells in patients with heterotopic ossification
2026-01-31 The expression profiling of serum circPHLPP2 and LncRNA ILF3 in colorectal cancer patients
2026-01-24 Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancer
2026-01-23 Homotypic membrane-powered electrochemical microfluidic analysis of extracellular vesicles for precise cancer diagnosis
2026-01-23 Identification of a circulating immunological signature as a liquid biopsy approach for the diagnosis of endometriosis
2026-01-21 Preoperative positive ctDNA analysis is associated with the tumor microenvironment, and the risk of recurrence in non-metastatic colorectal cancer
2026-01-19 Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study
2026-01-09 Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibility